International Multicenter Post Market Clinical Follow-up research for OCS-B® and Regenomer® in Socket Preservation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008267

Enrollment

Registered

2023-03-07

Start date

2023-03-08

Completion date

Unknown

Last updated

2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Group 1: Control, no socket preservation Group 2 : socket preservation with OCS-B® Xenomatrix Group 3 : socket preservation with Regenomer® Group 4 : socket preservation with OCS-B®

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Age 19-65 years - Single tooth extraction and implant - A person who agrees to participate in a clinical trial and signs a subject's consent form.

Exclusion criteria

Exclusion criteria: A person who has an uncontrolled internal disease A person with an uncontrolled hemorrhagic disease Others who are inappropriate to participate in clinical trials as judged by the person in charge of clinical trials as they may affect the results of clinical trials ethically

Design outcomes

Primary

Measure	Time frame
Change in volume of alveolar bone	—

Secondary

Measure	Time frame
Implant stability	—

Countries

Korea, Republic of

Contacts

Public ContactSEONHUI Park

Seoul National University Dental Hospital

p101911@naver.com+82-2-6256-3144

Outcome results